D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
VERA holding history
Vera Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VERA overviewAll 13F holders of VERAFull Q2 2026 holdings
- Shares (Q2 2026)
- 74,509
- Value
- $3.20M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 74,509 | $3.20M | <0.1% | +69,009+1,254.7% | Added | Holders |
| Q1 2026 | 5,500 | $221.3K | <0.1% | +5,500 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −15,154−100.0% | Sold out | Holders |
| Q2 2025 | 15,154 | $357.0K | <0.1% | +15,154 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −74,476−100.0% | Sold out | Holders |
| Q4 2024 | 74,476 | $3.15M | <0.1% | −55,990−42.9% | Reduced | Holders |
| Q3 2024 | 130,466 | $5.77M | <0.1% | −240,219−64.8% | Reduced | Holders |
| Q2 2024 | 370,685 | $13.4M | <0.1% | −230,351−38.3% | Reduced | Holders |
| Q1 2024 | 601,036 | $25.9M | <0.1% | +390,997+186.2% | Added | Holders |
| Q4 2023 | 210,039 | $3.23M | <0.1% | +51,853+32.8% | Added | Holders |
| Q3 2023 | 158,186 | $2.17M | <0.1% | +158,186 | New | Holders |